Articles by tag: glioblastoma

Breakthrough in glioblastoma treatment: NeoVax vaccine improves survival | ASCO 2026

Dana-Farber's personalized vaccine NeoVax showed median survival of 36.9 months in glioblastoma at ASCO 2026. Learn how immunotherapy works and who it suits.

Next-generation CAR-T: tumor neurobiology and brain cancer treatment

Scientists propose considering neurotransmitters for CAR-T cells in glioblastoma. A new approach to brain cancer therapy. Learn more.

Dubodencel Fast Track: treatment of glioblastoma and pancreatic cancer

Learn how dubodencel received its third Fast Track status from the FDA for treating glioblastoma, pancreatic cancer, and melanoma. Analysis of the dual-loading dendritic cell platform and prospects for patients.